Furthermore, studies on other disease targets, such as the role of the translocator protein (TSPO) in glioblastoma [52] and the potential role of GPR35 in diabetes and hypertension [53], provide valuable references for understanding the mechanism of action of PF4V1 in NMOSD. This evidence concerns the gene GPR35 and glioblastoma.